Boyd, Mark A <br/><br/>
Tenofovir alafenamide: safer, but questions remain.  [electronic resource] 

 -  The lancet. HIV  Apr 2016 
 - e148-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>2352-3018 
<br/><br/><label>Standard No.: </label>10.1016/S2352-3018(16)00039-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--therapeutic use<br/>Anti-HIV Agents--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>HIV Infections--drug therapy<br/>HIV-1<br/>Humans<br/>Organophosphonates--therapeutic use<br/>Tenofovir